Edinburgh Genetics Limited
iSource and licenceOfficial record from Companies House. Governance Register calculates the connections.Register edition compiled 8 November 2026.Contains public sector information licensed under the Open Government Licence v3.0.How we handle dataOverview
Edinburgh Genetics Limited's network
2 people4 organisationsExplore in 3Di2 listed on the board. 4 organisations share a board member with this company.The large node is Edinburgh Genetics Limited. The map shows two steps out from the public record. Hover a node to focus its connections; click one to open it.The board
2 listediDirectors and secretaries as filed at Companies House.| Name | Role | Since | On the board |
|---|---|---|---|
| Alasdair Young | Director | 2020 | 6y 7m |
| Yun Hei Chan | Director | 2019 | 6y 10m |
Recent news and events
From the public record
- 26 January 2026Confirmation statement made up to this dateCompanies House company file
- 31 December 2024Accounts made up to this dateCompanies House company file
Appointments, resignations and filings held in the Companies House data, and insolvency notices from The Gazette (Open Government Licence v3.0).
Public contracts won
iFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Contracts are matched to this organisation by company number, charity number or exact name and postcode, never by fuzzy name. For a company, contracts awarded to companies it owns through Companies House ownership data are included and labelled. A value shown as not stated is one the notice does not give (or gives as 0 or 1). Every contract links to its source notice.1 contract · £1m total published value
- iSource: Find a TenderPublished by Cabinet Office (Find a Tender Service). Notice 086264-2026. Awarded 10 Sep 2026. Open Government Licence v3.0.View the notice on Find a Tender ↗
- Buyer
- CENTRE FOR ENVIRONMENT, FISHERIES AND AQUACULTURE SCIENCE
- Value
- £1,000,000
- Awarded
- 10 Sep 2026
WhatCefas are seeking to establish a Framework for the provision of Next-Generation Sequencing (NGS) services, for a variety of NGS analyses methods, to support the delivery of numerous and varied research programmes that are utilising genomics. The framework is split into 4 Lots and Suppliers can bid for any number of Lots. Cefas intends to award up to 5 Contracts for each Lot, based on Suppliers meeting the required technical and pricing evaluation criteria. Cefas will then call-off from the framework for individual project requirements, as set out in the full Specification of Requirement document in the Bidder Pack. If a Supplier is awarded multiple Lots, one Contract will be awarded to cover the relevant Lots. The Contract implementation is expected to start in August 2026 for a period of 3 years with the option to extend for 2 further periods of 12 months each. Prices will be fixed for the initial 3 year period of the Contract. Prices may then be increased on an annual basis if the Contract is extended, in line with CPI. Lot 1 - Targeted Sequencing Suppliers will deliver targeted sequencing analyses, such as: • Amplicon sequencing and metabarcoding, utilising mainly 16S, 18S, COI
Board
Current officers
2iOccupation and nationality are held for only some companies and are not held for this one. Other boards counts directorships that are current in the Companies House officer data; it does not say whether the people are the same without a matching date of birth, and is not proof of any link between the companies.| Name | Role | Appointed | Other boards |
|---|---|---|---|
| Yun Hei Chan | Director | 31 December 2019 | 4 other current boards |
| Alasdair Young | Director | 16 March 2020 | 4 other current boards |
Source: Companies House officer data (appointments and resignations). Contains public sector information licensed under the Open Government Licence v3.0.
When board seats may change
iTime on the board since appointment. Many boards cap service at 6 to 9 years, so long-serving seats are the ones most likely to change.Who is on the board
iCounted from the dated Companies House officer record: the current directors only, past directors excluded.How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.2 directors on the board
- Alasdair Young Director · appointed 2020
- Yun Hei Chan Director · appointed 2019
Directors past 6 years
- Alasdair Young Director · appointed 2020
- Yun Hei Chan Director · appointed 2019
First-time vs portfolio directors
Portfolio (2)
- Alasdair Young Director · appointed 2020
- Yun Hei Chan Director · appointed 2019
Where else this board sits
The charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
Where to look Suggested search: succession planning for long-tenured seats.
Network
Network
iThe large node is Edinburgh Genetics Limited. Red nodes are organisations, white nodes are people. Dashed links are historical or inferred. Dashed blue-grey links are company secretaries. Click any node to explore.Most connected
Working out who is most connected...
Finances
Financial history
5 years heldiHover over the chart, or focus it and use the left and right arrow keys, to read each year. Every figure is also in the table.Scroll sideways to see every column.
| Year ending | Accounts | Turnover | Profit or loss | Net assets | Total assets less current liabilities | Cash | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | FRS102 | Not reported | Not reported | £97.07k | £114.13k | £82.40k | 6 |
| 31 December 2023 | FRS102 | Not reported | Not reported | £77.12k | £105.50k | £55.93k | 6 |
| 31 December 2022 | FRS102 | Not reported | Not reported | £190.31k | £223.93k | £273.45k | 5 |
| 31 December 2021 | FRS102 | Not reported | Not reported | £56.01k | £91.47k | £268.35k | 18 |
| 31 December 2020 | FRS102 | Not reported | Not reported | £86.78k | £184.87k | £367.15k | 23 |
- Absent is not zero. A figure shown as Not reported was not given in the accounts we hold. Small and micro companies do not have to file a profit and loss account, so turnover and profit are usually absent for them.
- Employees, cash and net assets are shown as Not shown when the filed figure is not possible (for example a negative headcount or negative cash).
Definitions
- Total assets less current liabilities
- Fixed assets plus current assets, minus what the company owes within a year. It is not total assets: cash can be larger than this figure when the company owes a lot in the short term. Where a filing does not give it, the table marks the fixed-assets figure used instead.
- Net assets
- What the company owns minus everything it owes. Also called shareholders' funds.
- Turnover
- Sales for the year. Only larger companies report it.
- Accounts
- The accounting framework named in the filing (for example FRS 102). Not stated means the filing does not say.
Source: Companies House accounts (iXBRL and XBRL), ten most recent years held, read by Governance Register from the monthly bulk accounts files. Contains public sector information licensed under the Open Government Licence v3.0.
Key dates and compliance
- Accounts category
- Total exemption fullSmall company accounts; the company is exempt from audit.
- Accounts last made up to
- 31 December 2024
- Next accounts due
- 31 December 2026 Due in 49 days
- Confirmation statement last made up to
- 26 January 2026
- Next confirmation statement due
- 9 February 2027 Not yet due
- Charges (secured loans)
- None registered
Filing history at Companies House (opens in a new tab)
Source: Companies House company file (1 October 2026) and, for new companies, the Companies Act timetable. Contains public sector information licensed under the Open Government Licence v3.0.
About
About this company
Companies House (opens in a new tab)- Company number
- SC650426
- Company type
- Private limited company
- Status
- Active
- Jurisdiction
- Scotland
- Incorporated
- 31 December 2019
- Registered office
- Pentlands Science Park, Bush Loan, Penicuik, EH26 0PZ
- Nature of business (SIC)
- 32500 Manufacture of medical and dental instruments and supplies
- 72110 Research and experimental development on biotechnology
- Group companies
- 2 in this ownership group See the group structure →
- Latest accounts
- 31 December 2024 (total exemption full)
Source: Companies House company file of 1 October 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Key dates and compliance
- Accounts category
- Total exemption fullSmall company accounts; the company is exempt from audit.
- Accounts last made up to
- 31 December 2024
- Next accounts due
- 31 December 2026 Due in 49 days
- Confirmation statement last made up to
- 26 January 2026
- Next confirmation statement due
- 9 February 2027 Not yet due
- Charges (secured loans)
- None registered
Filing history at Companies House (opens in a new tab)
Source: Companies House company file (1 October 2026) and, for new companies, the Companies Act timetable. Contains public sector information licensed under the Open Government Licence v3.0.
Same registered address
17iMatched on postcode and first line of the registered office, from the company file of 1 October 2026. A shared address is not evidence that companies are connected.17 companies are registered at this address.
- Moredun Scientific Limited
- Pentlands Science Park Limited
- Moredun Research Institute
- The Moredun Foundation
- Moredun Animal Health Limited
- Edinburgh BIO-Parks Limited
- Pentland Holdings Limited
- Inocul8 Limited
- Pentlands Immunologics Limited
- Wormvax Limited
- Evalu8 Science Limited
- Gener8 Science Limited
- Anticip8 Science Limited
- Edinburgh Genetics Group Limited
- Edinburgh Genetics Services Limited
- Northbridge Health Limited
Same sector and place
1iA sample. Matched on the main business code and postcode district, from the company file of 1 October 2026. Same sector and district is not evidence of any connection.1 other active company has the same main business code (32500 Manufacture of medical and dental instruments and supplies) and a registered office in the EH26 postcode district.
Recent news and events
From the public record
- 26 January 2026Confirmation statement made up to this dateCompanies House company file
- 31 December 2024Accounts made up to this dateCompanies House company file
Appointments, resignations and filings held in the Companies House data, and insolvency notices from The Gazette (Open Government Licence v3.0).
Ownership
Group structure
2 companies- Active
- Dissolved or closed
- Other status
- Not a UK company
- Current control
- Ceased control
- Shares a director
- Bar under a name: net assets or equity, where known
Loading the group structure…
Built from the corporate people with significant control records matched to UK companies (Companies House, Open Government Licence v3.0; ownership graph of 19 September 2026). Control is shown as the nature of control the controller declared; the group count includes only active majority holdings (more than 50%), so holdings of 25-50% are drawn but not counted. Overseas parents that are not on the UK register appear only when a company names them.
People with significant control
2| Name | Control | Notified | Ceased |
|---|---|---|---|
| Mr Alasdair YoungPerson · British |
| 16 March 2020 | Current |
| Mr Yun Hei ChanPerson · British |
| 31 December 2019 | Current |
2 current controllers and 0 former. Addresses and birth details are not shown.
Source: Companies House people with significant control data, snapshot of 1 October 2026. Contains public sector information licensed under the Open Government Licence v3.0. Companies are linked to their page where the name matches an owner company in our ownership graph.
Companies it holds shares or votes in
0| Company | Control | Notified | Ceased |
|---|---|---|---|
| Eg Genetics Limited | 75-100% shares, 75-100% votes, appoints directors | 29 December 2020 | Current |
0 companies where it holds a majority now (more than 50% of shares or votes, or the right to appoint or remove a majority of the directors); holdings of 25-50% are significant influence or control, not majority control. The whole group is in the structure above.